These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Euthyroid Graves' ophthalmopathy with negative autoantibodies. Cakir M J Natl Med Assoc; 2005 Nov; 97(11):1547-9. PubMed ID: 16334503 [TBL] [Abstract][Full Text] [Related]
3. Unilateral optic neuropathy as the initial manifestation of euthyroid Graves' disease. Arslan E; Yavaşoğlu I; Cildağ BM; Kocatürk T Intern Med; 2009; 48(22):1993-4. PubMed ID: 19915303 [TBL] [Abstract][Full Text] [Related]
4. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease. Gopinath B; Musselman R; Beard N; El-Kaissi S; Tani J; Adams CL; Wall JR Clin Exp Immunol; 2006 Jul; 145(1):56-62. PubMed ID: 16792674 [TBL] [Abstract][Full Text] [Related]
5. Ocular Manifestations and Clinical Implications of Serum Immunoglobulin G4 Levels in Graves' Ophthalmopathy Patients. Luo B; Yuan X; Wang W; Zhang J; Liu R; Hu W; Qi X; Xiang N; Chen L Ocul Immunol Inflamm; 2022 Apr; 30(3):580-587. PubMed ID: 33054491 [TBL] [Abstract][Full Text] [Related]
6. TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves' ophthalmopathy in untreated Japanese Graves' disease patients. Mukasa K; Yoshimura Noh J; Kouzaki A; Ohye H; Kunii Y; Watanabe N; Yoshihara A; Matsumoto M; Suzuki M; Ito K Endocr J; 2016; 63(2):151-7. PubMed ID: 26581710 [TBL] [Abstract][Full Text] [Related]
7. Clinical Implications of Immunoglobulin G4 to Graves' Ophthalmopathy. Yu SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ Thyroid; 2017 Sep; 27(9):1185-1193. PubMed ID: 28805160 [TBL] [Abstract][Full Text] [Related]
8. Euthyroid Graves' ophthalmopathy in a child. Peter S West Indian Med J; 2006 Oct; 55(5):360. PubMed ID: 17373308 [No Abstract] [Full Text] [Related]
10. Orbital pseudotumor: a differential diagnosis of Graves' ophthalmopathy. Caminha LS; Pinto ER; Sousa PA; Oliveira RA; Conceiçao FL; Vaisman M Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):85-8. PubMed ID: 21468526 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the correlation between serum autoantibodies against aldehyde dehydrogenase 2 and thyrotropin receptor in patients with Graves' ophthalmopathy. Lin CC; Chiu LW; Lee PY; Chen KJ; Cheng KC Indian J Ophthalmol; 2024 Feb; 72(2):298-299. PubMed ID: 38273693 [No Abstract] [Full Text] [Related]